About: Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1998 (uk) im September 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1998 (ast) scientific article published on 01 September 1998 (en)
publication date	wds:Q77163010-1E97619C-895E-4142-B1F5-4F79BBD40F75
publication date	1998-09-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q77163010-A9D2EF44-9B63-458E-91EA-0921D6D59582 wds:Q77163010-D9D3E878-36D8-4D59-B68D-92BE5474221E wds:Q77163010-DA5C8597-8F7A-4C63-BD91-60C9447BDD80 wds:Q77163010-DA73EFEF-1466-4C91-9DCC-2B523B1F091D
author name string	D E Myers O Ek L M Chelstrom T Zeren
rdfs:label	Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase (en) Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase (nl)
skos:prefLabel	Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase (en) Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase (nl)
name	Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase (en) Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase (nl)
author	wds:Q77163010-2C58D0C1-3946-4701-B3F6-E0333572B499 wds:Q77163010-B993D7AD-2DE1-495A-B842-85EB34B33668
author	Paul S. Gaynon Fatih M. Uckun
title	wds:Q77163010-32473C0A-FDB8-4555-9154-D84FFB75B83C
title	Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase (en)
page(s)	wds:Q77163010-DD504758-B6EC-40E7-9DE1-7235EDE1A93C
page(s)	143-149
instance of	wds:Q77163010-AC2EFBD7-3025-4AB2-84D5-9110F75D2D9C
instance of	scholarly article
main subject	wds:Q77163010-41F11E37-6418-43A6-BF03-28E389D66AA4 wds:Q77163010-F1DA480E-93E7-461C-882C-2AA7966813D0
main subject	methylprednisolone chemotherapy
PubMed ID	wds:Q77163010-8495E50D-15EF-45B6-A04E-771445B5CC3E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9720724
PubMed ID	9720724
published in	wds:Q77163010-5E1354DB-0E6A-4A08-B9C4-1DD25E0D1D28
published in	Leukemia & Lymphoma
issue	wds:Q77163010-7E0294D6-83A1-41C6-ABB1-38E636426F06
volume	wds:Q77163010-700DBE6E-C574-4075-8CFA-6F4E627F4D85
issue	1-2
volume	31
DOI	wds:Q77163010-332A2D94-AED8-4ABB-9191-420D08A3580D
DOI	http://dx.doi.org/10.3109/10428199809057594
DOI	10.3109/10428199809057594
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77163010
is cites work of	The anti-CD19 antibody-drug conjugate SAR3419 prevents hematolymphoid relapse postinduction therapy in preclinical models of pediatric acute lymphoblastic leukemia. The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL Salvage therapy for refractory or relapsed acute lymphocytic leukemia Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts. Efficacy of an anti-CD138 immunotoxin and doxorubicin on drug-resistant and drug-sensitive myeloma cells Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy Receptor upregulation enhances cell surface receptor targeted therapies
is cites work of	wds:Q34186583-68D76EFD-B069-45DD-8A04-5F776312950A wds:Q37248354-1F9F31B5-4829-4A79-B52C-B0166314B3BA wds:Q35850028-7120668B-A181-4ABA-B686-921B8BE6DFF2 wds:Q40925402-9DD00D78-2154-495A-A55E-AA4A92D23370 wds:Q38262399-607BB2F5-A23D-4FA5-B7C2-EF4E3421A7E6 wds:Q34221738-EA27AD3B-402E-4F53-B547-CB21B00991F9 wds:Q78550608-4E5E80CD-8347-41D3-AFED-20FE4B932151 wds:Q36745332-D35AF277-A223-4561-A6E5-2BD8C12FC7BD

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software